Hybrid group (n = 5) | Non-hybrid group (n = 7) | P value | |
---|---|---|---|
Gestational age (week, mean ± SD) | 37.8 ± 3.2 | 40.5 ± 1.4 | 0.033 |
Birth weight (kg, mean ± SD) | 3.0 ± 0.6 | 3.3 ± 0.4 | ns |
Gender m/f | 2/3 | 4/3 | ns |
Genetic syndrome n (%) | 2 (40.0) | 1 (14.3) | ns |
Birth mode n spontaneous/caesarean section | 3/2 | 2/5 | ns |
Prenatal diagnosis of heart defect n | 1 (20) | 1 (14.3) | ns |
Preterm n (%) | 1 (20.0) | 0 (0) | ns |
Cardiac structural diagnosis n (%) | |||
IAA Type A | 2 (40.0) | 5 (71.4) | ns |
IAA Type B | 3 (60.0) | 2 (28.5) | ns |
IAA Type C | 0 (0) | 0 (0) | ns |
Aortic valve dysplasia | 2 (40.0) | 3 (42.9) | ns |
Mitral valve dysplasia | 1 (20.0) | 1 (14.3) | ns |
Ventricular septum defect | 4 (80) | 6 (85.8) | ns |
Truncus arteriosus communis | 1 (20.0) | 0 (0) | ns |
Aortopulmonary window | 0 (0) | 1 (14.3) | ns |
Left ventricular outflow tract obstruction | 3 (60.0) | 0 (0) | 0.02 |
Risk scores (mean ± SD) | |||
Rhodes score | − 0.59 ± 0.57 | − 0.44 ± 0.45 | ns |
CHSS-1 score | − 10.5 ± 18.3 | − 10.4 ± 9.3 | ns |
Discriminant score | − 0.17 ± 1.6 | + 0.12 ± 0.6 | ns |
CHSS-2 score | − 70 ± 16.4 | − 53.5 ± 17.5 | ns |